Table 2.
Variables | N (%) |
---|---|
Number of doses received of liposomal amphotericin B | |
Two doses (10 mg/kg) | 1 (0.4) |
Three doses (15 mg/kg) | 4 (1.6) |
Four doses (20 mg/kg) | 246 (98.0) |
Apparent adverse event(s) experienced | |
No | 129 (51.4) |
Yes | 122 (48.6) |
Apparent adverse event experienced* | |
Muscle-skeletal system | |
Back pain | 2 (0.8) |
Digestive system | |
Nausea and vomiting | 25 (10.0) |
Diarrhea | 20 (8.0) |
Dyspepsia | 12 (4.8) |
Jaundice | 2 (0.8) |
Respiratory system | |
Upper respiratory infection† | 39 (15.5) |
Pneumonia | 16 (6.4) |
Coagulation system | |
Epistaxis | 3 (1.2) |
Skin and appendages | |
Rash | 4 (1.6) |
Urinary tract infection | 4 (1.6) |
Unspecified infections | 6 (2.4) |
Apparent adverse event during infusion | |
Chills/rigor | 8 (3.2) |
Severe lip swelling | 3 (1.2) |
One or more symptoms recorded for each patient.
Includes cough and sore throat only.